SLC12A5 and epilepsy: Importantly, increased KCC2 function attenuates chemically-induced epileptiform activity in T906A/1007A mice, both in acute hippocampal slices and in vivo (Moore et al., 2018), suggesting that enhancing KCC2 activity through T906/1007 dephosphorylation may be an effective approach in epilepsy treatment.